| [1] |
中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2019年版)[J]. 中国癌症杂志，2019, 29(8)：609-680.
|
| [2] |
Helyer LK, Varnic M, Le LW, et al. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients[J]. Breast J, 2010，16(1)：48-54.
|
| [3] |
Disipio T, Rye S, Newman B, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis [J]. Lancet Oncol, 2013，14(6)：500-515.
|
| [4] |
Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial[J]. J Natl Cancer Inst, 2006，98(9)：599-609.
|
| [5] |
Gross JP, Whelan TJ, Parulekar WR, et al. Development and validation of a nomogram to predict lymphedema after axillary surgery and radiation therapy in women with breast cancer from the NCIC CTG MA.20 randomized trial[J]. Int J Radiat Oncol, 2019，105(1)：165-173.
|
| [6] |
Cariati M, Bains SK, Grootendorst MR, et al. Adjuvant taxanes and the development of breast cancer-related arm lymphoedema[J]. Br J Surg, 2015, 102(9)：1071-1078.
|
| [7] |
Nguyen TT, Hoskin TL, Habermann EB, et al. Breast cancer-related lymphedema risk is related to multidisciplinary treatment and not surgery alone: results from a large cohort study[J]. Ann Surg Oncol, 2017, 24(10)：2972-2980.
|
| [8] |
Thompson M, Korourian S, Henry-Tillman R, et al. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation[J]. Ann Surg Oncol, 2007, 14(6)：1890-1895.
|
| [9] |
Nos C, Lesieur B, Clough KB, et al. Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection[J]. Ann Surg Oncol, 2007, 14(9)：2490-2496.
|
| [10] |
贺青卿，岳涛，庄大勇. 乳腺癌术中腋窝逆向淋巴示踪研究进展[J]. 中华内分泌外科杂志，2014，8(2)：127-129.
|
| [11] |
王璐，许雪宁，朱妍慧，等. 腋窝逆向淋巴结示踪术在乳腺癌患者选择性腋窝淋巴结清扫中的应用[J/CD]. 中华乳腺病杂志(电子版), 2017，11(6)：325-330.
|
| [12] |
李琳，吴炅. 腋窝逆向淋巴示踪[J]. 外科理论与实践，2013，18(4)：400-404.
|
| [13] |
刘媛，陆云飞. 腋窝逆向淋巴示踪的临床实践及争议[J/CD]. 中华乳腺病杂志(电子版), 2017，11(6)：365-368.
|
| [14] |
岳涛，庄大勇，贺青卿，等. 腋窝逆向淋巴示踪预防乳腺癌患者上肢淋巴水肿的研究[J/CD]. 中华乳腺病杂志(电子版), 2014，8(2)：92-98.
|
| [15] |
贺青卿，朱见，庄大勇，等. 腋窝逆向淋巴示踪预防乳腺癌术后上肢水肿[J]. 国际外科学杂志，2013，40(3)：209-210.
|
| [16] |
Boughey JC, Suman VJ, Mittendorf EA, et al. Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance)[J]. Ann Surg, 2015，261(3)：547-552.
|
| [17] |
Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial[J]. Lancet Oncol, 2014，15(12)：1303-1310.
|
| [18] |
Sávolt Á， Péley G, Polgár C, et al. Eight-year follow up result of the OTOASOR trial: the optimal treatment of the axilla-surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer[J]. Eur J Surg Oncol, 2017，43(4)：672-679.
|
| [19] |
Boughey JC. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer[J]. JAMA, 2013，310(14)：1455.
|
| [20] |
Beek MA, Gobardhan PD, Schoenmaeckers EJ, et al. Axillary reverse mapping in axillary surgery for breast cancer: an update of the current status[J]. Breast Cancer Res Treat, 2016，158(3)：421-432.
|
| [21] |
Gennaro M, Maccauro M, Sigari C, et al. Selective axillary dissection after axillary reverse mapping to prevent breast-cancer-related lymphoedema[J]. Eur J Surg Oncol, 2013，39(12)：1341-1345.
|
| [22] |
Nos C, Kaufmann G, Clough KB, et al. Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection[J]. Ann Surg Oncol, 2008，15(9)：2550-2555.
|
| [23] |
Britton TB, Solanki CK, Pinder SE, et al. Lymphatic drainage pathways of the breast and the upper limb[J]. Nucl Med Commun, 2009，30(6)：427-430.
|
| [24] |
Noguchi M, Yokoi M, Nakano Y. Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancer[J]. J Surg Oncol, 2010，101(3)：217-221.
|
| [25] |
Suami H, Taylor GI, Pan W. The lymphatic territories of the upper limb: anatomical study and clinical implications[J]. Plast Reconstr Surg, 2007，119(6)：1813-1822.
|
| [26] |
Britton TB, Solanki CK, Pinder SE, et al. Lymphatic drainage pathways of the breast and the upper limb[J]. Nucl Med Commun, 2009，30(6)：427-430.
|
| [27] |
Tausch C, Baege A, Dietrich D, et al. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients？[J]. Eur J Surg Oncol, 2013，39(8)：880-886.
|
| [28] |
Yue T, Zhuang D, Zhou P, et al. A prospective study to assess the feasibility of axillary reverse mapping and evaluate its effect on preventing lymphedema in breast cancer patients[J]. Clin Breast Cancer, 2015，15(4)：301-306.
|
| [29] |
Yuan Q, Wu G, Xiao S, et al. Identification and preservation of arm lymphatic system in axillary dissection for breast cancer to reduce arm lymphedema events: a randomized clinical trial[J]. Ann Surg Oncol, 2019，26(11)：3446-3454.
|
| [30] |
Noguchi M, Noguchi M, Nakano Y, et al. Axillary reverse mapping using a fluorescence imaging system in breast cancer[J]. J Surg Oncol, 2012，105(3)：229-234.
|
| [31] |
Ikeda K, Ogawa Y, Komatsu H, et al. Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients[J]. World J Surg Oncol, 2012，10：233.
|
| [32] |
Ikeda K, Ogawa Y, Kajino C, et al. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients[J]. Eur J Surg Oncol, 2014，40(7)：818-823.
|
| [33] |
Faisal M, Sayed MG, Antonious K, et al. Prevention of lymphedema via axillary reverse mapping for arm lymph-node preservation following breast cancer surgery: a randomized controlled trial[J]. Patient Saf Surg, 2019，13：35.
|
| [34] |
Ma X, Wen S, Liu B, et al. Relationship between upper extremity lymphatic drainage and sentinel lymph nodes in patients with breast cancer[J]. J Oncol, 2019, 2019: 8 637 895.
|
| [35] |
Boneti C, Korourian S, Bland K, et al. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy[J]. J Am Coll Surg, 2008，206(5)：1038-1042.
|
| [36] |
Casabona F, Bogliolo S, Valenzano Menada M, et al. Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer patients[J]. Ann Surg Oncol, 2009，16(9)：2459-2463.
|
| [37] |
Ponzone R, Cont NT, Maggiorotto F, et al. Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer[J]. J Clin Oncol, 2009，27(33)：5547-5551.
|
| [38] |
Bedrosian I, Babiera GV, Mittendorf EA, et al. A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients[J]. Cancer, 2010, 116(11)：2543-2548.
|
| [39] |
Deng H, Chen L, Jia W, et al. Safety study of axillary reverse mapping in the surgical treatment for breast cancer patients[J]. J Cancer Res Clin, 2011，137(12)：1869-1874.
|
| [40] |
Rubio IT, Cebrecos I, Peg V, et al. Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast cancer[J]. J Surg Oncol, 2012，106(1)：89-93.
|
| [41] |
Gobardhan PD, Wijsman JH, van Dalen T, et al. ARM: axillary reverse mapping - The need for selection of patients [J]. Eur J Surg Oncol, 2012，38(8)：657-661.
|
| [42] |
Han JW, Seo YJ, Choi JE, et al. The efficacy of arm node preserving surgery using axillary reverse mapping for preventing lymphedema in patients with breast cancer[J]. J Breast Cancer, 2012，15(1)：91.
|
| [43] |
Connor C, Mcginness M, Mammen J, et al. Axillary reverse mapping: a prospective study in women with clinically node negative and node positive breast cancer[J]. Ann Surg Oncol, 2013，20(10)：3303-3307.
|
| [44] |
Schunemann E Jr, Dória MT, Silvestre JB, et al. Prospective study evaluating oncological safety of axillary reverse mapping[J]. Ann Surg Oncol, 2014，21(7)：2197-2202.
|
| [45] |
Beek MA, Gobardhan PD, Klompenhouwer EG, et al. Axillary reverse mapping (ARM) in clinically node positive breast cancer patients[J]. Eur J Surg Oncol, 2015，41(1)：59-63.
|
| [46] |
Ngui NK, French J, Kilby CJ, et al. Axillary reverse mapping in patients with breast cancer: is it oncologically safe？[J]. J Surg Oncol, 2016，113(7)：726-731.
|
| [47] |
Tummel E, Ochoa D, Korourian S, et al. Does axillary reverse mapping prevent lymphedema after lymphadenectomy？[J]. Ann Surg, 2017，265(5)：987-992.
|
| [48] |
Beek MA, Gobardhan PD, Klompenhouwer EG, et al. A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer[J]. Eur J Surg Oncol, 2020，46(1)：59-64.
|
| [49] |
Clough KB, Nasr R, Nos C, et al. New anatomical classification of the axilla with implications for sentinel node biopsy[J]. Br J Surg, 2010，97(11)：1659-1665.
|
| [50] |
Nos C, Clough KB, Bonnier P, et al. Upper outer boundaries of the axillary dissection. Result of the SENTIBRAS protocol: Multicentric protocol using axillary reverse mapping in breast cancer patients requiring axillary dissection [J]. Eur J Surg Oncol, 2016, 42(12)：1827-1833.
|
| [51] |
Suami H, Pan W, Mann GB, et al. The lymphatic anatomy of the breast and its implications for sentinel lymph node biopsy: A human cadaver study[J]. Ann Surg Oncol, 2008，15(3)：863-871.
|
| [52] |
Pavlista D, Eliska O. Analysis of direct oil contrast lymphography of upper limb lymphatics traversing the axilla - a lesson from the past - contribution to the concept of axillary reverse mapping[J]. Eur J Surg Oncol, 2012，38(5)：390-394.
|
| [53] |
Suami H, Pan W, Taylor GI. Changes in the lymph structure of the upper limb after axillary dissection: radiographic and anatomical study in a human cadaver[J]. Plast Reconstr Surg, 2007，120(4)：982-991.
|
| [54] |
Yuan Q, Wu G. ASO author reflections: Identification and preservation of axillary lymphatic system[J]. Ann Surg Oncol, 2019，26(S3)：823.
|
| [55] |
Ochoa DA. Axillary lymphatic evaluation: A solution to a complex problem[J]. Ann Surg Oncol, 2019，26(11)：3413-3414.
|
| [56] |
Tashiro K, Yamashita S, Koshima I, et al. Visualization of accessory lymphatic pathways in secondary upper extremity lymphedema using indocyanine green lymphography [J]. Ann Plast Surg, 2017, 79(4)：393-396.
|
| [57] |
Noguchi M, Noguchi M, Ohno Y, et al. Feasibility study of axillary reverse mapping for patients with clinically node-negative breast cancer[J]. Eur J Surg Oncol, 2016，42(5)：650-656.
|
| [58] |
Beek MA, Tetteroo E, Luiten EJT, et al. Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy[J]. Eur J Surg Oncol, 2016, 42(5)：672-678.
|